Fundstrat Granny Shots US Small- & Mid-Cap ETFGRNJ

GRNJ-the Fundstrat Granny Shots US Small- & Mid-Cap ETF-started life on ARCA this month with a mandate to own companies so small and mid-sized that their quarterly earnings calls are conducted in the break room between the coffee machine and the filing printer. The issuer’s marketing leaflet promises ‘high-octane growth at the intersection of disruption and elbow grease,’ yet the ETF’s top line simply reads ‘200 or so US small- and mid-cap equities chosen by rules you will not be shown.’ Nasdaq lists the fund ticker, confirms it trades on ARCA, and stops there; it does not reveal whether any actual granny is involved in stock selection or if the name is just a very optimistic metaphor. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/grnj)

The fund’s expense ratio of 0.55% sits between ‘cheap enough to ignore’ and ‘expensive enough to make you check the small print twice.’ According to the SEC EDGAR search page, the only public document on record is the initial registration statement; it names ARCA as the exchange, quotes the 0.55% fee, and offers no holdings list, no methodology paper, and no performance track record. In other words, the basket is invisible, the recipe is secret, and the only thing you can price today is the cost of the wrapper itself. (source: SEC EDGAR search for GRNJ, https://www.sec.gov/edgar/search/#/q=GRNJ)

FINRA’s fund analyzer crunches the numbers and spits out the mechanical realities: tracking difference versus the index, bid-ask spread, and the fact that the ETF is so new that even its first one-month performance sheet is still a draft. The issuer’s polished brochures calls the mandate ‘precision alpha extraction from the heartland of American enterprise,’ which in plain English means ‘we own a lot of companies you have never heard of and charge you 55 basis points to hold them.’ The fund’s stated objective is to track the performance of a small- and mid-cap US index, but the index itself is not named in any public source we can see. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)

The only chart route supplied in the evidence is the Nasdaq quote page for GRNJ, which gives live price, volume, and a 15-minute delayed candle. There are no moving-average overlays, no support or resistance lines, and no analyst estimates-because none are supplied. If you want to know what ‘granny shots’ refers to, the evidence is silent; the Nasdaq page simply confirms the ticker is live and tradable. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/grnj)

What changed this week is that GRNJ exists. What remains unproven is whether the portfolio is any good, what the index it tracks actually is, how the selection rules work, and whether any actual human or algorithm is doing anything more sophisticated than throwing darts at a Bloomberg terminal. Until the issuer publishes a holdings list, a methodology note, or a performance history, the fund remains a wrapper masquerading as a theme, and the only thing you can truly rely on is the 0.55% fee that arrives every year like clockwork.